Correlation between SACE (Subjective Angiographic Chemoembolization Endpoint) score and tumor response and its impact on survival after DEB-TACE in patients with hepatocellular carcinoma-Reference-Cited by-同舟云学术

Correlation between SACE (Subjective Angiographic Chemoembolization Endpoint) score and tumor response and its impact on survival after DEB-TACE in patients with hepatocellular carcinoma

Published:2019-07-23 Issue:10 Volume:44 Page:3463-3479
ISSN:2366-004X
Container-title:Abdominal Radiology
language:en
Short-container-title:Abdom Radiol

Author:

Habbel Victoria Susanne Antonia^ORCID,Zeile Martin,Stavrou Gregor Alexander,Wacker Frank,Brüning Roland,Oldhafer Karl-Jürgen,Rodt Thomas

Publisher

Springer Science and Business Media LLC

Subject

Urology,Gastroenterology,Radiology, Nuclear Medicine and imaging,Radiological and Ultrasound Technology

Link

http://link.springer.com/content/pdf/10.1007/s00261-019-02128-7.pdf

Reference35 articles.

1. http://gco.iarc.fr/today/data/factsheets/cancers/11-Liver-fact-sheet.pdf , 30.10.2018.

2. Stuver S TD (2008) Cancer of the Liver and Biliary Tract. In: Adami HO, Hunter D, Trichopoulos D, editors Textbook of Cancer Epidemiology 2nd ed New York:. https://doi.org/10.1093/acprof:oso/9780195311174.003.0012

3. Bruix J, Sherman M, American Association for the Study of Liver D (2011) Management of hepatocellular carcinoma: an update. Hepatology 53 (3):1020–1022. https://doi.org/10.1002/hep.24199

4. Forner A, Reig ME, de Lope CR, Bruix J (2010) Current strategy for staging and treatment: the BCLC update and future prospects. Seminars in liver disease 30 (1):61–74. https://doi.org/10.1055/s-0030-1247133

5. Forner A, Llovet JM, Bruix J (2012) Hepatocellular carcinoma. Lancet 379 (9822):1245–1255. https://doi.org/10.1016/s0140-6736(11)61347-0

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Locoregional interventional therapy for hepatocellular carcinoma: radiologic and clinical factors predictive of untreatable progression and time to untreatable progression;Frontiers in Pharmacology;2024-07-23

2. Intraarterial Therapies for the Management of Hepatocellular Carcinoma;Cancers;2022-07-10

3. A real-world study of Chinese hepatocellular carcinoma patients treated with TACE;EUR REV MED PHARMACO;2022

4. Integrated Liver Inflammatory Score Predicts the Therapeutic Outcome of Patients with Hepatocellular Carcinoma after Transarterial Chemoembolization;Journal of Vascular and Interventional Radiology;2021-08

5. Systemic Inflammation Response Index is a Prognostic Risk Factor in Patients with Hepatocellular Carcinoma Undergoing TACE;Risk Management and Healthcare Policy;2021-06